Neurotez, Inc. to Present at the 10th Annual Biotechnology Industry Organization (BIO) CEO & Investor Conference  
2/7/2008 9:01:10 AM

BRIDGEWATER, N.J.--(BUSINESS WIRE)--Neurotez, Inc., a company developing therapies for Alzheimer’s disease, today announced that Chief Executive Officer Dr. Nikolaos Tezapsidis will present an overview of the Company at the 10th Annual BIO CEO & Investor Conference in New York on Wednesday, February 13, 2008, 11:45am at the Park Avenue Suite of The Waldorf Astoria Hotel.